tiprankstipranks
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market

Artiva Biotherapeutics, Inc. (ARTV) Technical Analysis

Compare
17 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
10Bearish
Artiva Biotherapeutics, Inc.’s (ARTV) Moving Averages Convergence Divergence (MACD) indicator is -0.40, suggesting Artiva Biotherapeutics, Inc. is a Buy.
Artiva Biotherapeutics, Inc.’s (ARTV) 20-Day exponential moving average is 4.36, while Artiva Biotherapeutics, Inc.’s (ARTV) share price is $3.16, making it a Sell.
Artiva Biotherapeutics, Inc.’s (ARTV) 50-Day exponential moving average is 5.37, while Artiva Biotherapeutics, Inc.’s (ARTV) share price is $3.16, making it a Sell.

Artiva Biotherapeutics, Inc. (ARTV) Pivot Points

Mar 31, 2025, 03:56 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.16
3.35
3.44
3.63
3.73
3.92
4.01
Fibonacci
3.35
3.46
3.52
3.63
3.74
3.81
3.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Artiva Biotherapeutics, Inc. (ARTV) Moving Averages

Mar 31, 2025, 03:56 AM
Period
Simple
Exponential
MA5
3.65Sell
3.63Sell
MA10
4.19Sell
4.02Sell
MA20
4.67Sell
4.36Sell
MA50
4.76Sell
5.37Sell
MA100
7.93Sell
7.06Sell
MA200
Artiva Biotherapeutics, Inc.’s (ARTV) 10-Day exponential moving average is 4.02, while Artiva Biotherapeutics, Inc.’s (ARTV) share price is $3.16, making it a Sell.
Artiva Biotherapeutics, Inc.’s (ARTV) 100-Day exponential moving average is 7.06, while Artiva Biotherapeutics, Inc.’s (ARTV) share price is $3.16, making it a Sell.
Artiva Biotherapeutics, Inc.’s (ARTV) stock price is $3.16 and Artiva Biotherapeutics, Inc.’s (ARTV) 50-day simple moving average is 4.76, creating a Sell signal.
Artiva Biotherapeutics, Inc.’s (ARTV) stock price is $3.16 and Artiva Biotherapeutics, Inc.’s (ARTV) 100-day simple moving average is 7.93, creating a Sell signal.

Artiva Biotherapeutics, Inc. (ARTV) Technical Indicators

Mar 31, 2025, 03:56 AM
Name
Value
Implied Action
RSI (14)
34.71
Neutral
STOCH (9,6)
3.57
Buy
STOCHRSI (14)
2.91
Buy
MACD (12,26)
-0.40
Buy
ADX (14)
22.49
Neutral
Williams %R
-99.71
Buy
CCI (14)
-125.01
Buy
ATR (14)
0.66
-
Ultimate Oscillator
41.59
Neutral
ROC
-40.49
Sell
Artiva Biotherapeutics, Inc.’s (ARTV) Relative Strength Index (RSI) is 34.71, creating a Neutral signal.
Artiva Biotherapeutics, Inc.’s (ARTV) Trend Strength Indicator (ADX) is 22.49, creating a Neutral signal.
Artiva Biotherapeutics, Inc.’s (ARTV) Commodity Channel Index (CCI) is -125.01, creating a Buy signal.
Artiva Biotherapeutics, Inc.’s (ARTV) Price Rate of Change (ROC) is -40.49, creating a Sell signal.

FAQ

Is ARTV a Buy, Hold, or Sell?
Based on ARTV’s technical indicators, ARTV is a Sell.
    What is ARTV’s RSI (14)?
    ARTV’s RSI (14) is 34.71, which suggests ARTV is a Neutral.
      What is ARTV’s MACD?
      ARTV’s MACD is -0.40, which suggests ARTV is a Buy.
        What is ARTV’s 5-day moving average?
        ARTV’s 5-day moving average is 3.65, which suggests ARTV is a Sell.
          What is ARTV’s 20-day moving average?
          ARTV 20-day moving average is 4.67, which suggests ARTV is a Sell.
            What is ARTV’s 50-day moving average?
            ARTV’s 50-day moving average is 4.76, which suggests ARTV is a Sell.
              What is ARTV’s 200-day moving average?
              Currently, no data Available
              What is ARTV’s Williams % R (14)?
              ARTV’s Williams % R (14) is -99.71, which suggests ARTV is a Buy.
                What is ARTV’s CCI (14)?
                ARTV’s CCI (14) is -125.01, which suggests ARTV is a Buy.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis